Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Heliyon|October 21, 2024
Functional and morphological improvement of significant non-culprit coronary artery stenosis by LDL-C reduction with a PCSK9 antibody: Rationale and design of the randomized FITTER trialFrans B Mensink, Jonathan Los, Rohit M Oemrawsingh, et al.
The New England Journal of Medicine|August 27, 2021
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Enrico Frigoli, Dik Heg, et al.
JAMA Cardiology|June 29, 2017
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) CollaborationGennaro Giustino, Rafael Harari, Usman Baber, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 19, 2025
Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trialFrans B Mensink, Jonathan Los, Mohamed M Reda Morsy, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) CollaborationGennaro Giustino, Ioannis Mastoris, Usman Baber, et al.
Circulation. Cardiovascular Interventions|July 11, 2019
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsUsman Baber, Giulio G Stefanini, Gennaro Giustino, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 21, 2017
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusionsJiang Ming Fam, Soledad Ojeda, Roberto Garbo, et al.
JACC. Cardiovascular Interventions|January 6, 2018
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES InitiativeJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|January 15, 2016
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled TrialsUsman Baber, Gennaro Giustino, Samantha Sartori, et al.
The American Journal of Cardiology|July 16, 2015
Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsGennaro Giustino, Usman Baber, Giulio Giuseppe Stefanini, et al.
Pageof 19